Take-home naloxone in Australian hospitals - HOSPITAL PHARMACY PRACTICE UPDATE The purpose of this document is to provide guidance to facilitate the supply of take-home naloxone from hospital settings to individuals who may witness or experien…

Standard Instructions and Counseling for Naloxone Insufficient in the Era of Xylazine and Medetomidine Adulteration of Illicit Opioids.  Datta P, Waters K, White CM.  J Pharm Technol. 2025 Mar 17:87551225251326811. doi: 10.1177/875512252…

Environmental life cycle of fentanyl: from the cradle to an unknown grave.  Reid, D. J., Patel, K. F., Melville, A. M., Bailey, V. L., Omberg, K. M., & Lamoureux, L. R. (2025).  Journal of Environmental…

Adolescent Fentanyl Use: Toxicological Risks, Epidemiological Trends, and Public Health Strategies.  Sacco MA, Gualtieri S, Santos A, Mendes B, Aquila I.  Cureus. 2025 Feb 24;17(2):e79558. doi: 10.7759/cureus.79558. PMID: 40144416; PMCID…

Xylazine as an emerging new psychoactive substance; focuses on both 5-HT7 and κ-opioid receptors' molecular interactions and isosteric replacement.  Floresta G, Granzotto A, Patamia V, Arillotta D, Papanti GD, Guirguis A, Corkery JM, Mart…

Co-occurring illicit fentanyl use and psychiatric disorders in emergency department patients.  Downs A, Walter L, Shelton R, Li L.  Sci Rep. 2025 Apr 1;15(1):11192. doi: 10.1038/s41598-025-92311-2. PMID: 40169703; PMCID: PMC11962126. ht…